Slough, UK and Richmond, VA, 31 October 2017– Indivior PLC (LON: INDV) announced today that … Continue reading FDA Advisory Committees Recommend Approval of Indivior’s RBP-6000 for the Treatment of Opioid Use Disorder
Slough, UK and Richmond, VA, 31 October 2017– Indivior PLC (LON: INDV) announced today that … Continue reading FDA Advisory Committees Recommend Approval of Indivior’s RBP-6000 for the Treatment of Opioid Use Disorder
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
